QLD vs BIB
YTDYear to date
BIB wins+33.4 pts
Past year
BIB wins+57.5 pts
Fee
QLD winslower fee
Yield
Level
AUM
QLD128.7× more
2–1BIB wins
QLD and BIB · year-to-date · as of Nov 4, 2026 · AUM not scored
BIB vs S&P 500
1D$118.78 · +1.4% last sessionDividend-adjusted total return. S&P 500 uses VOO.CompareS&P 500+ Peer avg+ Add a fund
Return1D ▼1M3MYTD1Y3Y5YMAX
Total return+1.4%+6.0%+16.7%+49.0%+66.5%+202.6%+33.7%+1529.4%
Peer average+2.7%−24.2%−15.8%−3.6%−6.4%+113.0%+49.1%—
S&P 500 · VOO+0.3%−2.6%−1.7%+11.5%+11.9%+90.9%+77.5%+816.4%
ProShares BIB and Vanguard VOO · total return, dividends in · as of Nov 4, 2026
BIB’s Holdings
TodayIQMMProshares Genius Mny Mkt Etf16.9%GILD5.6%AMGN5.2%VRTX4.9%REGN3.9%MRNA3.5%RVMD1.6%BIIB1.5%ILMN1.4%RPRX1.2%ROIV1.0%UTHR1.0%INCY1.0%ARGX0.9%INSM0.9%GH0.9%VTRSALNYMEDPEXELASNDBBIO252 more
IQMMProshares Genius Mny Mkt Etf16.9%GILD5.6%AMGN5.2%VRTX4.9%REGN3.9%MRNA3.5%RVMDBIIBILMNRPRXROIVUTHR262 more
BiotechnologyAsset Management - BondsDrug Manufacturers - GeneralMedical - DiagnosticsDrug Manufacturers - SpecialtyMedical - Pharmaceuticals
ProShares BIB · 274 holdings · tile size = share of the fund · as of Nov 3, 2026
All 404 An Index ETFs
YTD| # | Trend | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | TQQQ | ProShares UltraPro QQQReadDesk | 0.94% | 0.8% | +15.5% | +15.5% | $32.5B | |
| 2 | SOXL | Direxion Daily Semiconductor Bull 3XReadDesk | 0.91% | 0.1% | +74.1% | +74.1% | $18.0B | |
| 3 | QLD | ProShares - Ultra QQQReadDesk | 0.96% | 0.2% | +15.6% | +15.6% | $13.2B | |
| 4 | SSO | ProShares - Ultra S&P500ReadDesk | 0.88% | 0.7% | +17.1% | +17.1% | $8.4B | |
| 5 | SPXL | Direxion Daily S&P 500 Bull 3XReadDesk | 0.95% | 0.5% | +22.5% | +22.5% | $6.5B | |
| 6 | SOXS | Direxion Daily Semiconductor Bear 3XReadDesk | 1.00% | 22.1% | −91.2% | −91.2% | $6.1B | |
| 7 | UPRO | ProShares - UltraPro S&P500ReadDesk | 0.88% | 0.8% | +22.1% | +22.1% | $5.2B | |
| 8 | TECL | Direxion Daily Technology Bull 3XReadDesk | 0.94% | 5.2% | +39.9% | +39.9% | $4.5B | |
| 9 | BULZ | MicroSectors Solactive FANG & Innovation 3X Leveraged ETNReadDesk | 0.95% | — | +4.5% | +4.5% | $2.2B | |
| 10 | FAS | Direxion Daily Financial Bull 3XReadDesk | 0.92% | 8.6% | +2.4% | +2.4% | $2.2B | |
| 11 | USD | ProShares Ultra SemiconductorsReadDesk | 0.94% | 0.6% | +32.3% | +32.3% | $2.2B | |
| 12 | SQQQ | ProShares - UltraPro Short QQQReadDesk | 0.94% | 7.6% | −35.2% | −35.2% | $2.0B | |
| 13 | TMF | Direxion Daily 20+ Year Treasury Bull 3XReadDesk | 1.01% | 4.8% | −19.0% | −19.0% | $2.0B | |
| 14 | TNA | Direxion Daily Small Cap Bull 3XReadDesk | 1.07% | 0.3% | +27.6% | +27.6% | $1.3B | |
| 15 | ROM | ProShares - Ultra TechnologyReadDesk | 0.93% | 0.0% | +35.4% | +35.4% | $1.1B | |
| 16 | BITX | 2x Bitcoin StrategyReadDesk | 2.75% | 9.1% | −39.3% | −39.3% | $1.0B |
1–16 of 404Page 1 of 26
An Index · current AUM · as of Nov 4, 2026
BIB Payouts by Year
5YLatest payout, Sep 2026
$0.08
a share · every quarter
0.2% yield
0.2% yield
5 years added up
$1.62 a share
$1.62 a share
ProShares BIB · per-share distributions by ex-date · 2022–2026
BIB’s Peers
YTD| # | Trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | QLD | ProShares - Ultra QQQReadVersus | 0.96% | 0.2% | +1.2% | +15.6% | +8.9% | $13.2B | |
| 2 | SSO | ProShares - Ultra S&P500ReadVersus | 0.88% | 0.7% | +0.6% | +17.1% | +16.4% | $8.4B | |
| 3 | USD | ProShares Ultra SemiconductorsReadVersus | 0.94% | 0.6% | +4.8% | +32.3% | +15.1% | $2.2B | |
| 4 | ROM | ProShares - Ultra TechnologyReadVersus | 0.93% | 0.0% | +2.6% | +35.4% | +22.3% | $1.1B | |
| 5 | BITX | 2x Bitcoin Strategy ETFReadVersus | 2.75% | 9.1% | +3.2% | −39.3% | −63.8% | $1.0B | |
| 6 | BIB | ProShares Ultra Nasdaq BiotechnologyThis fund | 1.17% | 0.2% | +1.4% | +49.0% | +66.5% | $102M |
#9 of 85 this year · #172 cheapest of 230 · sorted by assetsOpen the Leveraged table →
BIB and its peer group · total return · as of Nov 4, 2026
Cards for This View
BIB’s Top 10 Holdings
Today45.7%of BIB sits in these 10
ProShares BIB · weight in the fund · as of Nov 3, 2026
BIB’s Holdings
TodayIQMMProshares Genius Mny Mkt Etf16.9%GILD5.6%AMGN5.2%VRTX4.9%REGN3.9%MRNA3.5%RVMD1.6%BIIB1.5%ILMN1.4%RPRX1.2%ROIV1.0%UTHR1.0%INCY1.0%ARGX0.9%INSM0.9%GH0.9%VTRSALNYMEDPEXELASNDBBIO252 more
IQMMProshares Genius Mny Mkt Etf16.9%GILD5.6%AMGN5.2%VRTX4.9%REGN3.9%MRNA3.5%RVMDBIIBILMNRPRXROIVUTHR262 more
BiotechnologyAsset Management - BondsDrug Manufacturers - GeneralMedical - DiagnosticsDrug Manufacturers - SpecialtyMedical - Pharmaceuticals
ProShares BIB · 274 holdings · tile size = share of the fund · as of Nov 3, 2026
BIB vs Peer Average
YTDBIBAvsBPeer average
1D+1.4%+2.7%
1M+6.0%−24.2%
3M+16.7%−15.8%
YTD+49.0%−3.6%
1Y+66.5%−6.4%
3Y+202.6%+113.0%
5Y+33.7%+49.1%
5–2BIB wins
229 An index peers · each row scaled to its leader